Evidence map›Paper›PMID 36551114›Full record

ArticleBiosensors2022

Current Status of Measurement Accuracy for Total Hemoglobin Concentration in the Clinical Context.

Elena Stawschenko, Tim Schaller, Benjamin Kern, Berit Bode, Frank Dörries, Kristina Kusche-Vihrog, Hartmut Gehring, Philipp Wegerich

Abstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The impact of sensor application site on continuous noninvasive haemoglobin trends.Computational and structural biotechnology journal · 2025
    Article
  6. Role of Anemia in Dementia Risk Among Veterans With Incident CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023
    Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elena StawschenkoDepartment of Anaesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany.
Tim SchallerDepartment of Anaesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany.
Benjamin KernMedical Sensors and Devices Laboratory, Lübeck University of Applied Sciences, 23562 Luebeck, Germany.ORCID 0000-0003-1930-3100
Berit BodeDepartment of Anaesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany.
Frank DörriesNorthern Scientific Tec & Integration GmbH, Kollaustr. 11-13, 22525 Hamburg, Germany.
Kristina Kusche-VihrogInstitute of Physiology, University of Luebeck, 23562 Luebeck, Germany.
Hartmut GehringDepartment of Anaesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany.
Philipp WegerichInstitute of Biomedical Engineering, University of Luebeck, 23562 Luebeck, Germany.

Funding

European Union - Regional Development Fund (ERDF) and the State Government of Land Schleswig-Holstein for the project "Cross-Innovation-Center- TANDEM Phase III (TANDEM III - CIC) Application No. 124 20 003; Project No. LPW-E/1.1.1/1521
6 · The paper itself

Abstract

objectiveThe main objective of this investigation is to provide data about the accuracy of total hemoglobin concentration measurements with respect to clinical settings, and to devices within the categories of point-of-care and reference systems. In particular, tolerance of hemoglobin concentrations below 9 g/dL that have become common in clinical practice today determines the need to demonstrate the limits of measurement accuracy in patient care.

methodsSamples extracted from six units of heparinized human blood with total hemoglobin concentrations ranging from 3 to 18 g/dL were assigned to the test devices in a random order. The pool of test devices comprised blood gas analyzers, an automatic hematology analyzer, a laboratory reference method, and the point-of-care system HemoCue. To reduce the pre-analytic error, each sample was measured three times. Due to the characteristics of the tested devices and methods, we selected the mean values of the data from all these devices, measured at the corresponding total hemoglobin concentrations, as the reference. MAIN

resultsThe measurement results of the test devices overlap within strict limits (R

conclusionsA clinically relevant change of +/- 0.5 g/dL of total hemoglobin concentration can be detected with all selected devices and methods. Compliance with more stringent definitions-these are the relative differences of 5 % in relation to the corresponding reference values and the clinically adapted thresholds in the format of a tolerance level analysis-was achieved by the clinical devices assessed here.

Indexed as

HemoglobinsPoint-of-Care SystemsBlood Gas AnalysisHumansHemoglobinsaccuracyconcentrationhemoglobinpatient blood managementtolerance level analysis

Identifiers

PMID36551114
PMCPMC9775510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.